Cargando…

Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons

Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder characterized by deficient synthesis of dopamine and serotonin. It presents in early infancy, and causes severe developmental disability and lifelong motor, behavioral, and autonomic symptoms including oculogyric crises...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearson, Toni S., Gupta, Nalin, San Sebastian, Waldy, Imamura-Ching, Jill, Viehoever, Amy, Grijalvo-Perez, Ana, Fay, Alex J., Seth, Neha, Lundy, Shannon M., Seo, Youngho, Pampaloni, Miguel, Hyland, Keith, Smith, Erin, de Oliveira Barbosa, Gardenia, Heathcock, Jill C., Minnema, Amy, Lonser, Russell, Elder, J. Bradley, Leonard, Jeffrey, Larson, Paul, Bankiewicz, Krystof S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275582/ https://www.ncbi.nlm.nih.gov/pubmed/34253733 http://dx.doi.org/10.1038/s41467-021-24524-8

Ejemplares similares

Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial
por: Ciesielska, Agnieszka, et al.
Publicado: (2017)

Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate
por: Sebastian, Waldy San, et al.
Publicado: (2014)

Carbidopa-Based Modulation of the Functional Effect of the AAV2-hAADC Gene Therapy in 6-OHDA Lesioned Rats
por: Ciesielska, Agnieszka, et al.
Publicado: (2015)

An Update on Gene Therapy Approaches for Parkinson’s Disease: Restoration of Dopaminergic Function
por: Van Laar, Amber D., et al.
Publicado: (2021)

Aromatic L-Amino Acid Decarboxylase (AADC) Is Crucial for Brain Development and Motor Functions
por: Shih, De-Fen, et al.
Publicado: (2013)

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency
por: Wassenberg, Tessa, et al.
Publicado: (2017)

Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
por: Christine, Chadwick W., et al.
Publicado: (2019)

Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington’s disease
por: Hadaczek, Piotr, et al.
Publicado: (2016)

Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review
por: Rizzi, Susanna, et al.
Publicado: (2022)

Axonal transport of AAV9 in nonhuman primate brain
por: Green, Foad, et al.
Publicado: (2016)

Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus
por: Fusco, Carlo, et al.
Publicado: (2021)

MR-Guided Delivery of AAV2-BDNF into the Entorhinal Cortex of Non-Human Primates
por: Nagahara, Alan H., et al.
Publicado: (2018)

A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
por: Smith, Adam B, et al.
Publicado: (2021)

Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
por: Christine, Chadwick W., et al.
Publicado: (2022)

Compound Heterozygosis in AADC Deficiency and Its Complex Phenotype in Terms of AADC Protein Population
por: Bisello, Giovanni, et al.
Publicado: (2022)

A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France
por: Smith, Adam B, et al.
Publicado: (2022)

Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study
por: Smith, Adam B., et al.
Publicado: (2021)

Symptoms and impacts of aromatic l-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function
por: Williams, Kate, et al.
Publicado: (2022)

Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France
por: Smith, Adam B, et al.
Publicado: (2021)

Convection-Enhanced Delivery of AAV2-PrPshRNA in Prion-Infected Mice
por: Ahn, Misol, et al.
Publicado: (2014)

Tyrosine Hydroxylase (TH)- and Aromatic-L-Amino Acid Decarboxylase (AADC)-Immunoreactive Neurons of the Common Marmoset (Callithrix jacchus) Brain: An Immunohistochemical Analysis
por: Karasawa, Nobuyuki, et al.
Publicado: (2007)

Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study
por: Simons, Claire L., et al.
Publicado: (2023)

Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
por: Ohno, Kousaku, et al.
Publicado: (2018)

Biochemical diagnosis of aromatic-L-amino acid decarboxylase deficiency (AADCD) by assay of AADC activity in plasma using liquid chromatography/tandem mass spectrometry
por: Civallero, Gabriel, et al.
Publicado: (2022)

ADENO-ASSOCIATED VIRUS TYPE 6 IS RETROGRADELY TRANSPORTED IN THE NON-HUMAN PRIMATE BRAIN
por: Sebastian, Waldy San, et al.
Publicado: (2013)

Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System
por: Hadaczek, Piotr, et al.
Publicado: (2011)

Role of Endothelial AADC in Cardiac Synthesis of Serotonin and Nitrates Accumulation
por: Rouzaud-Laborde, Charlotte, et al.
Publicado: (2012)

Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
por: Hwu, Paul Wuh‐Liang, et al.
Publicado: (2021)

Axonal transport of adeno-associated viral vectors is serotype-dependent
por: Salegio, Ernesto A., et al.
Publicado: (2012)

Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease
por: Nutt, John G., et al.
Publicado: (2020)

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency
por: Tai, Chun-Hwei, et al.
Publicado: (2022)

Blood, urine and cerebrospinal fluid analysis in TH and AADC deficiency and the effect of treatment
por: Wassenberg, Tessa, et al.
Publicado: (2021)

The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology
por: Fiandaca, Massimo S., et al.
Publicado: (2011)

Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy
por: Salegio, Ernesto A., et al.
Publicado: (2014)

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
por: Fiandaca, Massimo S., et al.
Publicado: (2012)

AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients
por: Pearson, Toni S., et al.
Publicado: (2020)

Single-centre parental survey of paediatric rehabilitation services for children with cerebral palsy
por: Bican, Rachel, et al.
Publicado: (2021)

Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease
por: Richardson, R Mark, et al.
Publicado: (2020)

Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience
por: Grahn, Amy Y., et al.
Publicado: (2009)

Manual Abilities and Cognition in Children with Cerebral Palsy: Do Fine Motor Skills Impact Cognition as Measured by the Bayley Scales of Infant Development?
por: Invencao Cabral, Thais, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fuvm40jj7rpk75d961erqci6n9